| Tretinoin | Approved Investigational Nutraceutical | NIPBL | 25836 |
downregulated | Tretinoin results in decreased expression of NIPBL mRNA | 5p13.2 | |
| Tretinoin | Approved Investigational Nutraceutical | NIPSNAP1 | 8508 |
downregulated | Tretinoin results in decreased expression of NIPSNAP1 mRNA | 22q12.2 | |
| Tretinoin | Approved Investigational Nutraceutical | NIPSNAP1 | 8508 |
upregulated | Tretinoin results in increased expression of NIPSNAP1 mRNA | 22q12.2 | |
| Tretinoin | Approved Investigational Nutraceutical | NKAIN2 | 154215 |
upregulated | Tretinoin results in increased expression of NKAIN2 mRNA | 6q22.31 | |
| Tretinoin | Approved Investigational Nutraceutical | NKG7 | 4818 |
upregulated | Tretinoin results in increased expression of NKG7 mRNA | 19q13.41 | |
| Tretinoin | Approved Investigational Nutraceutical | NKX2-1 | 7080 |
downregulated | Tretinoin results in decreased expression of NKX2-1 mRNA | 14q13.3 | |
| Tretinoin | Approved Investigational Nutraceutical | NKX3-1 | 4824 |
upregulated | Tretinoin results in increased expression of NKX3-1 mRNA | 8p21.2 | |
| Tretinoin | Approved Investigational Nutraceutical | NLGN1 | 22871 |
upregulated | Tretinoin results in increased expression of NLGN1 mRNA | 3q26.31 | |
| Tretinoin | Approved Investigational Nutraceutical | NLGN3 | 54413 |
downregulated | Tretinoin results in decreased expression of NLGN3 mRNA | Xq13.1 | |
| Tretinoin | Approved Investigational Nutraceutical | NMB | 4828 |
upregulated | Tretinoin results in increased expression of NMB mRNA | 15q25.2 | |
| Tretinoin | Approved Investigational Nutraceutical | NME1 | 4830 |
downregulated | Tretinoin results in decreased expression of NME1 mRNA | 17q21.33 | |
| Tretinoin | Approved Investigational Nutraceutical | NMI | 9111 |
upregulated | Tretinoin results in increased expression of NMI mRNA | 2q23.3 | |
| Tretinoin | Approved Investigational Nutraceutical | NMU | 10874 |
upregulated | Tretinoin results in increased expression of NMU mRNA | 4q12 | |
| Tretinoin | Approved Investigational Nutraceutical | NNAT | 4826 |
downregulated | Tretinoin results in decreased expression of NNAT mRNA | 20q11.23 | |
| Tretinoin | Approved Investigational Nutraceutical | NOC2L | 26155 |
downregulated | Tretinoin results in decreased expression of NOC2L mRNA | 1p36.33 | |
| Tretinoin | Approved Investigational Nutraceutical | NOC3L | 64318 |
downregulated | Tretinoin results in decreased expression of NOC3L mRNA | 10q23.33 | |
| Tretinoin | Approved Investigational Nutraceutical | NOL3 | 8996 |
upregulated | Tretinoin results in increased expression of NOL3 mRNA | 16q22.1 | |
| Tretinoin | Approved Investigational Nutraceutical | NOL4L | 140688 |
downregulated | Tretinoin results in decreased expression of NOL4L mRNA | 20q11.21 | |
| Tretinoin | Approved Investigational Nutraceutical | NOLC1 | 9221 |
downregulated | Tretinoin results in decreased expression of NOLC1 mRNA | 10q24.32 | |
| Tretinoin | Approved Investigational Nutraceutical | NOP16 | 51491 |
downregulated | Tretinoin results in decreased expression of NOP16 mRNA | 5q35.2 | |
| Tretinoin | Approved Investigational Nutraceutical | NOP56 | 10528 |
downregulated | Tretinoin results in decreased expression of NOP56 mRNA | 20p13 | |
| Tretinoin | Approved Investigational Nutraceutical | NOTCH1 | 4851 |
downregulated | Tretinoin results in decreased expression of NOTCH1 mRNA | 9q34.3 | |
| Tretinoin | Approved Investigational Nutraceutical | NOTCH2 | 4853 |
upregulated | Tretinoin results in increased expression of NOTCH2 mRNA | 1p12 | |
| Tretinoin | Approved Investigational Nutraceutical | NOX3 | 50508 |
downregulated | Tretinoin results in decreased expression of NOX3 mRNA | 6q25.3 | |
| Tretinoin | Approved Investigational Nutraceutical | NOX4 | 50507 |
downregulated | Tretinoin results in decreased expression of NOX4 mRNA | 11q14.3 | |